|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 600 13th Street, NW |
Address2 | Suite 500 |
| City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 26683-12
|
||||||||
|
6. House ID# 305940000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Leah Evangelista |
Date | 7/22/2024 4:52:48 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues regarding childrens health care coverage and access to care under Medicaid, CHIP, the Exchanges, and private insurance
Issues regarding the annual Notice of Benefit and Payment Parameters for the Exchanges and private insurance
H.R. 2412 The Helping Kids Cope Act
S.2372/HR. 4758 - Accelerating Kids Access to Care Act
Issues regarding childrens and mothers health specifically continuous eligibility for children in Medicaid and CHIP, CHIP permanency
Issues regarding childrens mental health and the national emergency in childrens mental health, including mental health parity, the mental health workforce and related access issues.
Issue regarding Medicaid supplemental payments and directed payments
Issues related to Health Information Technology, interoperability, information blocking, and cybersecurity
Pediatric Access to Critical Healthcare (PATCH) Act, and issues regarding pediatric health care infrastructure and capacity
Issues regarding the importance of Medicaid to children, including military and veteran families
Issues regarding Medicaid support for providers caring for children on Medicaid, including DSH payments
Issues regarding Children's Hospitals Graduate Medical Education (CHGME) program and funding
Issues related to 340B Drug Pricing Program, prescription drug pricing, drug shortages, high-cost drugs/therapies and pharmaceutical supply chain, including H.R. 3290
Issues related to pediatric workforce, Medicare GME, the Pediatric Specialty Loan Repayment Program, and Title VII and VIII
Issues regarding Organ Procurement and Transplantation Network
S. 3029/H.R. 6085 PREEMIE Reauthorization Act
Issues regarding the Medicaid unwinding
Issues regarding surprise billing, bad debt, and price transparency in health care
Issues regarding pediatric pandemic and disaster preparedness and response and emergency preparedness
Issues regarding food security and nutrition
Issues regarding drugs and medical device shortages and high costs
Issues related to the regulation of laboratory developed tests
Issues regarding prescribing of drugs via telehealth
Issues related to mental health services in schools
Issues related to pediatric cancer and the Moonshot
Issues regarding Artificial Intelligence (AI)
H.R. 1117, Advancing Safe Medications for Moms and Babies Act of 2023
H.R. 4189, CONNECT for Health Act
H.R. 1110, KEEP Telehealth Options Act
H.R. 5541, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
Issues regarding the Public Health Emergency Unwinding
Issues involving Site Neutral payment legislation, including H.R. 3281 and H.R. 3561
S. 1884/H.R. 3713, Mental Health Services for Students Act
H.R. 2389, The Resident Shortage Reduction Act
S. 1774/H.R. 3761 the Assist Act
H.R. 2665, Supporting Safety Net Hospitals Act
H.R. 2584/S.2768, Safety form Violence for Healthcare employees (Save) Act
H.R. 3046, Medical Student Education Authorization Act
S. 2556, Improving CARE for Youth Act
S. 2647/H.R. 5012, SHINE for Autumn Act of 2023
S. 923/H.R. 4933, Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023
S. 2362/H.R. 3008, Drug Shortage Prevention Act of 2023
S. 1409, Kids Online Safety Act
S. 1769/H.R. 3805, the Kickstarting Innovative Demonstrations Supporting (KIDS) Health Act.
H.R. 5804, Mental Health Infrastructure Improvement Act
H.R. 5976 /S. 3060 Youth Mental Health Research Act
S. 3364, Kid PROOF Act of 2023
H.R. 6664 Innovation for Pediatric Drugs Act of 2023
H.R. 7808, the Early Action and Responsiveness Lifts Youth (EARLY) Minds Act
H.R. 7153/S. 3679 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
S. 3757 Congenital Heart Futures Reauthorization Act of 2024
H.R. 6960 Emergency Medical Services for Children Reauthorization Act of 2024
H.R. 3391 Gabriella Miller Kids First Research Act 2.0
H.R. 6963 Pediatric Cancer Drug Supply Act
H.R. 3433/ S. 2897, Give Kids A Chance Act
H.R. 7384, Creating Hope Reauthorization Act.
H.R. 6664, Innovation in Pediatric Drugs Act
S. 4298: Esthers Law
Issues regarding oversight and implementation of EPSDT
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Executive Office of the President (EOP), Labor - Dept of (DOL), Food & Drug Administration (FDA), Agriculture - Dept of (USDA), Drug Enforcement Administration (DEA), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cynthia |
Whitney |
|
|
|
Leah |
Evangelista |
|
|
|
Aimee |
Ossman |
|
|
|
Jan |
Kaplan |
|
|
|
Elizabeth |
Brown |
|
|
|
Natalie |
Torentinos |
|
|
|
Darian |
Burrell-Clay |
|
|
|
Kaleigh |
Koudela |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues regarding childrens health care coverage and access to care under Medicaid and CHIP, including oversight and implementation of EPSDT and guidance to states
Issues related to eligibility and enrollment, access to care and payment in response to CMS RFI on Medicaid and CHIP
Issues related to implementation of aspects of childrens health coverage under Medicaid and CHIP, including unwinding of the Public Health Emergency.
Issues regarding childrens and mothers health specifically continuous eligibility for children in Medicaid and CHIP
Issues regarding mental health parity, the mental health workforce
Issue regarding Medicaid supplemental payments, including DSH and directed payments
S.2372/HR. 4758 - Accelerating Kids Access to Care Act
Issues regarding the importance of Medicaid to military and veteran families
Issues related to pediatric telehealth
H.R. 1117, Advancing Safe Medications for Moms and Babies Act of 2023
Issues regarding the Public Health Emergency Unwinding
Issues regarding 340B including, H.R. 3561
Issues regarding payment for organ procurement
Issues regarding hospital at home requirements for children
Issues regarding equitable access to high-cost therapies for children
Issues regarding out of state care for children enrolled in Medicaid
Issues regarding Medicare GME
Issues regarding the Inpatient Prospective Payment System
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cynthia |
Whitney |
|
|
|
Leah |
Evangelista |
|
|
|
Aimee |
Ossman |
|
|
|
Jan |
Kaplan |
|
|
|
Elizabeth |
Brown |
|
|
|
Natalie |
Torentinos |
|
|
|
Darian |
Burrell-Clay |
|
|
|
Kaleigh |
Koudela |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Issues regarding efforts to improve health care delivery for children covered by TRICARE
Issues regarding reimbursement under TRICARE
Issues regarding the importance of Medicaid to military and veteran families
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Brown |
|
|
|
Jan |
Kaplan |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for Health Resources and Services Administration (HRSA), including Childrens Hospitals Graduate Medical Education program and other workforce programs, the Maternal and Child Health Block Grant, and Family 2 Family Centers, Funding for Title VII & Title VIII Health Resource and Services Administration (HRSA) workforce programs
Funding for the Centers for Disease Control and Prevention gun violence prevention research
Funding for the Substance Abuse and Mental Health Services Administration (SAMHSA) Community Mental Health Services Block Grant, including a set aside for prevention and early intervention services
Funding for the Pediatric Mental Health Care Access Program
Funding for and implementation of Pediatric Subspecialty Loan Forgiveness Program
Funding for the Emergency Medical Services for Children (EMSC) Program
Funding for the Pediatric Disaster Care Program.
Funding for the National Institutes of Health (NIH), including the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Funding for Department of Labor, Employee Security Benefits Administration (EBSA), to implement and enforce the Mental Health Parity and Addiction Equity Act.
Funding for the Department of Justice STOP School Violence Program.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cynthia |
Whitney |
|
|
|
Elizabeth |
Brown |
|
|
|
Leah |
Evangelista |
|
|
|
Aimee |
Ossman |
|
|
|
Jan |
Kaplan |
|
|
|
Darian |
Burrell-Clay |
|
|
|
Kaleigh |
Koudela |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Issues related to mental health in schools and childrens hospital partnerships with schools to address mental health
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cynthia |
Whitney |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |